Pulmonx (LUNG) Return on Capital Employed (2020 - 2025)
Pulmonx (LUNG) reported Return on Capital Employed of 47.7% for Q3 2025, down 934.0% year-over-year from 5.72% in Q3 2024, and down 6.05% quarter-over-quarter from 44.99% in Q2 2025.
Pulmonx (LUNG) Return on Capital Employed (2020 - 2025) Analysis & Trends
Pulmonx (LUNG) has 6 years of Return on Capital Employed data on file, last reported at 47.7% in Q3 2025.
- Return on Capital Employed for Q3 2025 came in at 47.7%, down 934.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 47.7% (down 934.0% YoY), and the FY2024 annual result was 39.56%, down 146.0% from the prior year.
- Return on Capital Employed retreated to 47.7% in Q3 2025 per LUNG's latest filing, from 44.99% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 15.77% in Q1 2021 and troughed at 47.7% in Q3 2025.
- A 5-year average of 32.92% and a median of 34.56% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2022: Return on Capital Employed decreased 30 bps in 2021, then slumped 1151 bps in 2022.
- A 5-year view of Return on Capital Employed shows it stood at 21.17% in 2021, then slumped by 54 bps to 32.68% in 2022, then slipped by 20 bps to 39.14% in 2023, then declined by 5 bps to 41.02% in 2024, then dropped by 16 bps to 47.7% in 2025.
- Business Quant data shows LUNG's Return on Capital Employed at 47.7% in Q3 2025, 44.99% in Q2 2025, and 43.79% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -47.70% |
| Jun 30, 2025 | -44.99% |
| Mar 31, 2025 | -43.79% |
| Dec 31, 2024 | -41.02% |
| Sep 30, 2024 | -38.37% |
| Jun 30, 2024 | -38.90% |
| Mar 31, 2024 | -40.08% |
| Dec 31, 2023 | -39.14% |
| Sep 30, 2023 | -37.16% |
| Jun 30, 2023 | -34.56% |
| Mar 31, 2023 | -32.91% |
| Dec 31, 2022 | -32.68% |
| Sep 30, 2022 | -30.35% |
| Jun 30, 2022 | -26.45% |
| Mar 31, 2022 | -23.89% |
| Dec 31, 2021 | -21.17% |
| Sep 30, 2021 | -19.63% |
| Jun 30, 2021 | -16.91% |
| Mar 31, 2021 | -15.77% |
| Dec 31, 2020 | -20.87% |